Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Cash And Cash Equivalents : $0.08 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings Cash And Cash Equivalents?

Zhong Yuan Bio-Technology Holdings's quarterly cash and cash equivalents declined from Sep. 2022 ($0.32 Mil) to Mar. 2023 ($0.28 Mil) but then stayed the same from Mar. 2023 ($0.28 Mil) to Sep. 2023 ($0.08 Mil).

Zhong Yuan Bio-Technology Holdings's annual cash and cash equivalents declined from Mar. 2021 ($0.20 Mil) to Mar. 2022 ($0.10 Mil) but then increased from Mar. 2022 ($0.10 Mil) to Mar. 2023 ($0.28 Mil).

Zhong Yuan Bio-Technology Holdings Cash And Cash Equivalents Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings Cash And Cash Equivalents Chart

Zhong Yuan Bio-Technology Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Mar19

Mar20

Mar21

Mar22

Mar23

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.01

0.06

0.20

0.10

0.28

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Cash And Cash Equivalents	Get a 7-Day Free Trial								0.01	0.10	0.32	0.28	0.08

Zhong Yuan Bio-Technology Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Zhong Yuan Bio-Technology Holdings (OTCPK:ZHYBF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Zhong Yuan Bio-Technology Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG

Website

https://www.zybioholdings.com

Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.

Executives

Tingting Chang	director, 10 percent owner, officer: CEO	RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy	director, 10 percent owner, officer: president,secretary,treasurer	215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop	director, 10 percent owner, officer: Vice President	9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines